Vitruvias Therapeutics
Eliot Murray joined Vitruvias in January of 2018, after having consulted with the company during its startup phase and Series A capital raise. In his role as Chief Financial Officer, he is responsible for all financial and accounting operations of the company. Eliot brings strong financial acumen to the team by way of unique experiences across diversified industries.
This person is not in any offices
Vitruvias Therapeutics
Vitruvias is a specialty generic pharmaceutical business focused on the development and marketing of generic products with either (i) complex APIs that are difficult to source, or (ii) finished dosage forms that are inherently difficult to manufacture.